[HTML][HTML] GSK-3 and Tau: a key duet in Alzheimer's disease
CL Sayas, J Ávila - Cells, 2021 - mdpi.com
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …
[HTML][HTML] Role of NRF2 in ovarian cancer
G Tossetta, S Fantone, E Montanari, D Marzioni… - Antioxidants, 2022 - mdpi.com
Among gynaecologic malignancies, ovarian cancer is one of the most dangerous, with a
high fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …
high fatality rate and relapse due to the occurrence of chemoresistance. Many researchers …
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder
with no current cure. One of the important therapeutic approaches of AD is the inhibition of β …
with no current cure. One of the important therapeutic approaches of AD is the inhibition of β …
MicroRNA-17–92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats
Background and Purpose—Multipotent mesenchymal stromal cell (MSC) harvested
exosomes are hypothesized as the major paracrine effectors of MSCs. In vitro, the miR-17 …
exosomes are hypothesized as the major paracrine effectors of MSCs. In vitro, the miR-17 …
Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases
Abstract Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with
over 100 known substrates to deal with. How does GSK3 maintain control to selectively …
over 100 known substrates to deal with. How does GSK3 maintain control to selectively …
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
L Wang, J Li, L Di - Medicinal Research Reviews, 2022 - Wiley Online Library
Abstract Glycogen synthase kinase‐3 (GSK3) is a highly evolutionarily conserved
serine/threonine protein kinase first identified as an enzyme that regulates glycogen …
serine/threonine protein kinase first identified as an enzyme that regulates glycogen …
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
AK Rines, K Sharabi, CDJ Tavares… - Nature reviews Drug …, 2016 - nature.com
Type 2 diabetes mellitus is characterized by the dysregulation of glucose homeostasis,
resulting in hyperglycaemia. Although current diabetes treatments have exhibited some …
resulting in hyperglycaemia. Although current diabetes treatments have exhibited some …
[HTML][HTML] In vivo base editing of post-mitotic sensory cells
Programmable nucleases can introduce precise changes to genomic DNA through
homology-directed repair (HDR). Unfortunately, HDR is largely restricted to mitotic cells, and …
homology-directed repair (HDR). Unfortunately, HDR is largely restricted to mitotic cells, and …
Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality
Microtubule-associated protein tau is essential for microtubule assembly and stabilization.
Hyperphosphorylation of the microtubule-associated protein tau plays an important …
Hyperphosphorylation of the microtubule-associated protein tau plays an important …
[HTML][HTML] In silico molecular docking analysis of karanjin against alzheimer's and parkinson's diseases as a potential natural lead molecule for new drug design …
Parkinson's disease (PD) and Alzheimer's disease (AD) are neurodegenerative disorders
that have emerged as among the serious health problems of the 21st century. The …
that have emerged as among the serious health problems of the 21st century. The …